fda glp-1 warning october 2025 GLP-1s in 2026: What Brokers Need to Know 2025 Novel Small Molecule FDA

10.1002/jnr.21349

doi: 10.1111/dom.12824 [DOI] [PubMed] [Google Scholar] 32

While blockbuster GLP-1 drugs continue to reach new heights in popularity, they're not without potential downsides, like bizarre side effects such as "Ozempic feet." And while they boast impressive blood sugar and weight loss results average weight lost is nearly 10% over a year making one mistake could result in the pounds coming right back on, new research finds

The entire field of view was exposed to excitation wavelengths of 340 nm (exposure time, 50 ms) and 380 nm (exposure time, 40 ms)

Groenewegen et al., 2020

Medicine, 6(9), 102331